50 Emerging Medical Technology Companies to be Showcased at Medtech Insight's In3 EUROPE Investment and Partnering Conference in Brussels, Belgium; Sept. 20-21, 2005, The Crowne Plaza Brussels City Centre Hotel.NEWPORT BEACH Newport Beach, residential and resort city (1990 pop. 66,643), Orange co., S Calif., on Newport Bay and the Pacific Ocean; inc. 1906. It is a popular seaside resort and yachting center. Manufactures include electrical and medical equipment, computers, boats, and adhesives. , Calif. -- Medtech Insight, a division of Windhover wind·hov·er n. Chiefly British A kestrel. Information, has announced that 16 early-stage medical technology companies from around the world are already confirmed to present at its "Investment In Innovation (In3) EUROPE: A Preview of Early-Stage Medical Technology Companies" conference in Brussels, Belgium, Sept. 20 and 21, 2005, out of the 50 companies that will be showcased in all. In3 EUROPE, Medtech Insight's first "Investment In Innovation" medical technology strategic partnering and investment event outside of the U.S., will be held at The Crowne Plaza This article or section needs sources or references that appear in reliable, third-party publications. Alone, primary sources and sources affiliated with the subject of this article are not sufficient for an accurate encyclopedia article. Brussels City Centre Hotel, and will bring together 50 emerging medical technology companies from around the world seeking funding, acquisition and/or strategic partnership with major medical technology and investment dealmakers. Presenting companies confirmed thus far for In3 EUROPE include: ABMI ABMI Autologous Bone Marrow Infusion , Aeres Medical, Biomarker Technologies, Biomedix, Biophan-Europe, HIRUDICA, Medical Tactile tactile /tac·tile/ (tak´til) pertaining to touch. tac·tile adj. 1. Perceptible to the sense of touch; tangible. 2. Used for feeling. 3. , QuiCare, Scientific Intake, SenTec, Skeletal Kinetics kinetics: see dynamics. Kinetics (classical mechanics) That part of classical mechanics which deals with the relation between the motions of material bodies and the forces acting upon them. , Spinelix, Suriasis, Valor valor a rodenticide no longer marketed because of toxicity in horses causing dehydration, abdominal pain, hindlimb weakness, inappetence, fishy smell in urine. Called also N-3-pyridyl methyl N1-p-nitrophenyl urea. Medical, Vascular Reconditioning, and ViOPtix. Regularly updated event details will be posted on the Medtech Insight Web site, at http://www.medtechinsight.com/in3-europe-01.html. The In3 EUROPE program will also feature presentations by Olav Bergheim, general partner at Domain Associates, a leading healthcare venture capital firm, and Stefan Widensohler, president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of KRAUTH Medical. The conference will conclude with an interactive industry panel discussion moderated by David Cassak, managing partner at Windhover Information. Event co-sponsors include Battelle, Business Wire, Factory, Ronald Trahan Associates, and TforG. The company's past U.S. "Investment In Innovation" conferences have hosted nearly 550 early-stage presenting medical companies, making it one of the most successful networking and partnering events in the medical device industry. For more information or to register to attend the In3 EUROPE event, or if your early-stage company is interested in presenting, contact Scott Pantel of Medtech Insight at 949-219-0150, or 888-290-2225 in the U.S., e-mail in3@medtechinsight.com, or visit the Medtech Insight Web site at http://www.medtechinsight.com/in3-europe-01.html. Through June 30, attendees registering for the conference can save $400 off the $1,495 registration fee. A division of Windhover Information Inc., Medtech Insight is the leading provider of business information and market intelligence for the medical technology marketplace. For more on the company's products and services, please see www.medtechinsight.com. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion